Assessing Lantheus Holdings (LNTH) Valuation As New ASCO 2026 Oncology Data Nears Publication

Simply Wall St.05-31

Lantheus Holdings (LNTH) is drawing fresh attention after announcing that new clinical and real world oncology data will be featured at the 2026 American Society of Clinical Oncology Annual Meeting in...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2639025106?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155","is_english":true,"pubTime":"2026-05-31 05:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2639025106","market":"hk","top_or_hot":-1,"title":"Assessing Lantheus Holdings (LNTH) Valuation As New ASCO 2026 Oncology Data Nears Publication","media":"Simply Wall St.","content":"<div>\n<p>Lantheus Holdings (LNTH) is drawing fresh attention after announcing that new clinical and real world oncology data will be featured at the 2026 American Society of Clinical Oncology Annual Meeting in...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-lnth/lantheus-holdings/news/assessing-lantheus-holdings-lnth-valuation-as-new-asco-2026\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Assessing Lantheus Holdings (LNTH) Valuation As New ASCO 2026 Oncology Data Nears Publication</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAssessing Lantheus Holdings (LNTH) Valuation As New ASCO 2026 Oncology Data Nears Publication\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-05-31 05:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-lnth/lantheus-holdings/news/assessing-lantheus-holdings-lnth-valuation-as-new-asco-2026><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Lantheus Holdings (LNTH) is drawing fresh attention after announcing that new clinical and real world oncology data will be featured at the 2026 American Society of Clinical Oncology Annual Meeting in...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-lnth/lantheus-holdings/news/assessing-lantheus-holdings-lnth-valuation-as-new-asco-2026\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4198","symbol_name":"医疗保健用品","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-lnth/lantheus-holdings/news/assessing-lantheus-holdings-lnth-valuation-as-new-asco-2026","article_id":"2639025106","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-lnth/lantheus-holdings/news/assessing-lantheus-holdings-lnth-valuation-as-new-asco-2026","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2639025106","pubTimestamp":1780175439,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Lantheus Holdings (LNTH) is drawing fresh attention after announcing that new clinical and real world oncology data will be featured at the 2026 American Society of Clinical Oncology Annual Meeting in Chicago.\nSee our latest analysis for Lantheus Holdings.\nThe stock has pulled back slightly in the past week, but a 30 day share price return of 22.34% and year to date share price return of 47.61% suggest momentum has been building. The 5 year total shareholder return of over 3x highlights how...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4198":"医疗保健用品","BK4585":"ETF&股票定投概念","LNTH":"Lantheus Holdings, Inc.","BK4588":"碎股"},"translate_title":"随着新的ASCO 2026肿瘤学数据即将发布，评估Lantheus Holdings(LNTH)估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LNTH":1.5},"content_text":"Lantheus Holdings (LNTH) is drawing fresh attention after announcing that new clinical and real world oncology data will be featured at the 2026 American Society of Clinical Oncology Annual Meeting in Chicago. See our latest analysis for Lantheus Holdings. The stock has pulled back slightly in the past week, but a 30 day share price return of 22.34% and year to date share price return of 47.61% suggest momentum has been building. The 5 year total shareholder return of over 3x highlights how longer term holders have been rewarded. If developments in oncology and AI supported imaging interest you, it is worth widening your search with a screener focused on 37 healthcare AI stocks With shares around US$99.30, Lantheus trades at a discount to the average analyst price target and to one intrinsic value estimate. This raises a core question for investors: is there still a buying opportunity here, or is the market already pricing in future growth? AdvertisementMost Popular Narrative: 4.6% Undervalued At a last close of $99.30 versus a narrative fair value of $104.08, the current price sits slightly below what the most followed model implies, and that gap is built on a detailed view of Lantheus's radiodiagnostic and royalty pipeline.  Multiple new product launches within the next 18 months, including the new F-18 PSMA PET, MK-6240, OCTEVY, and PNT2003, are set to diversify the revenue base, mitigate concentration risk, and open additional growth channels in oncology and neuroendocrine tumor imaging, supporting both top-line and future earnings expansion.  Read the complete narrative. Want to see how this pipeline story turns into a valuation number? The narrative leans on measured revenue growth, firmer margins, and a future earnings multiple that sits below today’s sector average. Curious which specific assumptions have the biggest impact on that fair value gap and how sensitive the outcome is to small changes in growth? Result: Fair Value of $104.08 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, the story can shift quickly if PYLARIFY faces sharper pricing pressure than expected, or if newer radiodiagnostic launches are slower to gain traction. Find out about the key risks to this Lantheus Holdings narrative. Next Steps Given the mix of enthusiasm around the pipeline and clear concerns on execution risk, it makes sense to review the full picture yourself. To see how those worries and potential upsides line up before you act, take a look at the 4 key rewards and 1 important warning sign. Looking for more investment ideas? If this Lantheus story caught your attention, do not stop here. Use the Simply Wall St Screener to uncover fresh opportunities that match your style.  Target quality at a discount by reviewing companies in the 46 high quality undervalued stocks before prices move away from you. Focus on resilience and sleep easier at night by scanning the 62 resilient stocks with low risk scores for businesses with steadier profiles. Get ahead of the crowd by checking the screener containing 22 high quality undiscovered gems that combine strong fundamentals with limited market attention.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2639025106","isCrawlerRequest":true}